Zhi Tong Cai Jing·2025-08-07 15:16Core Viewpoint - Spring Medical (01858) announced an investment in the Nanchang Defu Phase IV Equity Investment Fund Partnership, focusing on growth and mature companies/projects in the healthcare industry, aligning with the company's strategic development direction [1] Investment Details - The company, as a limited partner, invested 50 million RMB, representing 9.2105% of the fund's total shares [1] - The investment aims to leverage the experience and resource advantages of the partners to enhance the company's operational and capital integration [1] Strategic Implications - The investment is expected to promote a virtuous cycle of collaborative development, enhancing the company's core competitiveness and overall profitability [1] - This move is aligned with the company's goal of achieving sustainable, safe, healthy, and stable high-quality development [1]